Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 10
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2303)
- Volume 19, 2023 (86)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 10, 2014
Trabectedin for advanced soft tissue sarcomas: optimizing use
Reid A, Martin-Liberal J, Benson C
Therapeutics and Clinical Risk Management 2014, 10:1003-1011
Published Date: 12 December 2014
Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications
Abolfotouh MA, Salam M, Bani-Mustafa A, White D, Balkhy HH
Therapeutics and Clinical Risk Management 2014, 10:993-1001
Published Date: 8 December 2014
Low perfusion index affects the difference in glucose level between capillary and venous blood
Acar N, Ozcelik H, Cevik AA, Ozakin E, Yorulmaz G, Kebapci N, Bilge U, Bilgin M
Therapeutics and Clinical Risk Management 2014, 10:985-991
Published Date: 20 November 2014
Current perspectives on bisphosphonate treatment in Paget’s disease of bone
Wat WZM
Therapeutics and Clinical Risk Management 2014, 10:977-983
Published Date: 20 November 2014
Vulnerable COPD patients with comorbidities: the role of roflumilast
Lipari M, Kale-Pradhan PB
Therapeutics and Clinical Risk Management 2014, 10:969-976
Published Date: 18 November 2014
Risk of Essure microinsert abdominal migration: case report and review of literature
Ricci G, Restaino S, Di Lorenzo G, Fanfani F, Scrimin F, Mangino FP
Therapeutics and Clinical Risk Management 2014, 10:963-968
Published Date: 17 November 2014
Cardiorenal syndrome type 2: from diagnosis to optimal management
De Vecchis R, Baldi C
Therapeutics and Clinical Risk Management 2014, 10:949-961
Published Date: 12 November 2014
A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality
Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN
Therapeutics and Clinical Risk Management 2014, 10:937-948
Published Date: 18 November 2014
Acceleration training for managing nonalcoholic fatty liver disease: a pilot study
Oh S, Shida T, Sawai A, Maruyama T, Eguchi K, Isobe T, Okamoto Y, Someya N, Tanaka K, Arai E, Tozawa A, Shoda J
Therapeutics and Clinical Risk Management 2014, 10:925-936
Published Date: 7 November 2014
Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women
Qi S, Xin R, Guo WN, Liu Y
Therapeutics and Clinical Risk Management 2014, 10:915-923
Published Date: 4 November 2014
Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S
Therapeutics and Clinical Risk Management 2014, 10:913-914
Published Date: 28 October 2014
Engineering practice variation through provider agreement: a cluster-randomized feasibility trial
McCarren M, Twedt EL, Mansuri FM, Nelson PR, Peek BT
Therapeutics and Clinical Risk Management 2014, 10:905-912
Published Date: 28 October 2014
Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report
Ifteni P, Moga MA, Burtea V, Correll CU
Therapeutics and Clinical Risk Management 2014, 10:901-904
Published Date: 23 October 2014
Pharmacotherapy in the cardiac catheterization laboratory: evolution and recent developments
Thind GS, Parida R, Gupta N
Therapeutics and Clinical Risk Management 2014, 10:885-900
Published Date: 21 October 2014
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
Shin S, Lee S
Therapeutics and Clinical Risk Management 2014, 10:875-883
Published Date: 14 October 2014
Post-mastectomy radiotherapy can improve survival in breast cancer patients aged 35 years or younger with four or more positive nodes but not in one to three positive nodes
Wu S, Li Q, Zhou J, Sun J, Li F, Lin Q, He Z
Therapeutics and Clinical Risk Management 2014, 10:867-874
Published Date: 9 October 2014
Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital
Jiang SP, Chen J, Zhang XG, Lu XY, Zhao QW
Therapeutics and Clinical Risk Management 2014, 10:861-866
Published Date: 9 October 2014
Lobomycosis: epidemiology, clinical presentation, and management options
Francesconi VA, Klein AP, Santos AP, Ramasawmy R, Francesconi F
Therapeutics and Clinical Risk Management 2014, 10:851-860
Published Date: 9 October 2014
Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients
Lee YJ
Therapeutics and Clinical Risk Management 2014, 10:841-850
Published Date: 7 October 2014
Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course
Baldi F, Fuso L, Arrighi E, Valente S
Therapeutics and Clinical Risk Management 2014, 10:825-839
Published Date: 7 October 2014
Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease
González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, Martínez-Sánchez C
Therapeutics and Clinical Risk Management 2014, 10:815-823
Published Date: 6 October 2014
JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
Therapeutics and Clinical Risk Management 2014, 10:807-814
Published Date: 9 October 2014
The dexmedetomidine concentration required after remifentanil anesthesia is three-fold higher than that after fentanyl anesthesia or that for general sedation in the ICU
Kunisawa T, Fujimoto K, Kurosawa A, Nagashima M, Matsui K, Hayashi D, Yamamoto K, Goto Y, Akutsu H, Iwasaki H
Therapeutics and Clinical Risk Management 2014, 10:797-806
Published Date: 4 October 2014
Is hypoalbuminemia a prognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients?
Hassan K, Fadi H
Therapeutics and Clinical Risk Management 2014, 10:787-795
Published Date: 3 October 2014
Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review
Yuen HK, Cunningham MA
Therapeutics and Clinical Risk Management 2014, 10:775-786
Published Date: 1 October 2014
Effects of hyperbaric oxygenation therapy on symptomatic pneumocephalus
Paiva WS, Andrade AF, Figueiredo EG, Amorim RL, Prudente M, Teixeira MJ
Therapeutics and Clinical Risk Management 2014, 10:769-773
Published Date: 6 October 2014
Clinical management and therapeutic outcome of infertile couples in southeast Nigeria
Menuba IE, Ugwu EO, Obi SN, Lawani LO, Onwuka CI
Therapeutics and Clinical Risk Management 2014, 10:763-768
Published Date: 1 October 2014
A fatal case of Trichosporon asahii fungemia and pneumonia in a kidney transplant recipient during caspofungin treatment
Yang MF, Gao HN, Li LJ
Therapeutics and Clinical Risk Management 2014, 10:759-762
Published Date: 30 September 2014
Efficacy of tramadol as a preincisional infiltration anesthetic in children undergoing inguinal hernia repair: a prospective randomized study
Numanoğlu KV, Ayoğlu H, Tatlı D, Er E
Therapeutics and Clinical Risk Management 2014, 10:753-758
Published Date: 25 September 2014
Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
Gedik H, Şimşek F, Kantürk A, Yildirmak T, Arica D, Aydin D, Demirel N, Yokuş O
Therapeutics and Clinical Risk Management 2014, 10:743-752
Published Date: 17 September 2014
Application of caspofungin in China compared with amphotericin B and fluconazole
Zhang CY, Cheng JY, Jiang Y, Liu JY
Therapeutics and Clinical Risk Management 2014, 10:737-741
Published Date: 10 September 2014
Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
Hutajulu SH, Kurnianda J, Tan IB, Middeldorp JM
Therapeutics and Clinical Risk Management 2014, 10:721-736
Published Date: 5 September 2014
Magnetoledtherapy in the treatment of wounds after surgical procedures of the knee joint
Pasek J, Pasek T, Sieroń A
Therapeutics and Clinical Risk Management 2014, 10:717-720
Published Date: 2 September 2014
Mutation p.R156H of KRT10 responsible for severe phenotype of epidermolytic ichthyosis in a Chinese family
Li Z, Liu Q, Wang A, Wang H, Li C
Therapeutics and Clinical Risk Management 2014, 10:713-715
Published Date: 1 September 2014
Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
Katz EG, Tan RBW, Rittenberg D, Hellstrom WJ
Therapeutics and Clinical Risk Management 2014, 10:701-711
Published Date: 27 August 2014
Lymphangioleiomyomatosis: differential diagnosis and optimal management
Xu KF, Lo BH
Therapeutics and Clinical Risk Management 2014, 10:691-700
Published Date: 21 August 2014
Emerging treatments in type 2 diabetes: focus on canagliflozin
Rosiak M, Grzeszczak S, Kosior DA, Postuła M
Therapeutics and Clinical Risk Management 2014, 10:683-689
Published Date: 21 August 2014
Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications
Chou TY, Hong BY
Therapeutics and Clinical Risk Management 2014, 10:665-681
Published Date: 20 August 2014
Advanced prostate cancer – patient survival and potential impact of enzalutamide and other emerging therapies
Patel NK, Finianos A, Whitaker KD, Aragon-Ching JB
Therapeutics and Clinical Risk Management 2014, 10:651-664
Published Date: 16 August 2014
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Giordano N, Nuti R
Therapeutics and Clinical Risk Management 2014, 10:641-650
Published Date: 13 August 2014
Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection
Molino CGRC, Carnevale RC, Rodrigues AT, Visacri MB, Moriel P, Mazzola PG
Therapeutics and Clinical Risk Management 2014, 10:631-639
Published Date: 7 August 2014
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
Aikawa N, Kawasaki Y
Therapeutics and Clinical Risk Management 2014, 10:621-629
Published Date: 5 August 2014
Double-balloon tamponade in the management of postpartum hemorrhage: a case series
Kavak SB, Kavak EC, Demirel I, Ilhan R
Therapeutics and Clinical Risk Management 2014, 10:615-620
Published Date: 2 August 2014
Clinical and economic studies of eptifibatide in coronary stenting
Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S
Therapeutics and Clinical Risk Management 2014, 10:603-614
Published Date: 2 August 2014
New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
Leibert E, Danckers M, Rom WN
Therapeutics and Clinical Risk Management 2014, 10:597-602
Published Date: 29 July 2014
Optimal management of renal artery fibromuscular dysplasia
Gottsäter A, Lindblad B
Therapeutics and Clinical Risk Management 2014, 10:583-595
Published Date: 28 July 2014
Determinants of decision-to-intervention time in the management and therapeutic outcome of emergency gynecological surgeries in south east Nigeria
Onyebuchi AK, Lawani LO, Nkwo PO, Iyoke CA, Onoh RC, Ajah LO
Therapeutics and Clinical Risk Management 2014, 10:577-582
Published Date: 28 July 2014
Abciximab in the management of acute myocardial infarction with ST-segment elevation: evidence-based treatment, current clinical use, and future perspectives
Dziewierz A, Rakowski T, Dudek D
Therapeutics and Clinical Risk Management 2014, 10:567-576
Published Date: 18 July 2014
HIV-associated lipodystrophy: a review from a Brazilian perspective
Alves MD, Brites C, Sprinz E
Therapeutics and Clinical Risk Management 2014, 10:559-566
Published Date: 17 July 2014
Profile of saxagliptin in the treatment of type 2 diabetes: focus on Japanese patients
Konya H, Yano Y, Matsutani S, Tsunoda T, Ikawa T, Kusunoki Y, Matsuo T, Miuchi M, Katsuno T, Hamaguchi T, Miyagawa JI, Namba M
Therapeutics and Clinical Risk Management 2014, 10:547-558
Published Date: 11 July 2014
Ethical and legal framework and regulation for off-label use: European perspective
Lenk C, Duttge G
Therapeutics and Clinical Risk Management 2014, 10:537-546
Published Date: 12 July 2014
Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice
Lozano-Blázquez A, Calvo-Pita C, Carbajales-Álvarez M, Suárez-Gil P, Martínez-Martínez F, Calleja-Hernández MA
Therapeutics and Clinical Risk Management 2014, 10:527-535
Published Date: 9 July 2014
Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges
Mann AP, Grebenciucova E, Lukas RV
Therapeutics and Clinical Risk Management 2014, 10:517-525
Published Date: 1 July 2014
Severe complications after negative pressure wound therapy in burned wounds: two case reports
Ren H, Li Y
Therapeutics and Clinical Risk Management 2014, 10:513-516
Published Date: 1 July 2014
Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
He K, Shi JC, Mao XM
Therapeutics and Clinical Risk Management 2014, 10:505-511
Published Date: 30 June 2014
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
Gentile I, Buonomo AR, Zappulo E, Minei G, Morisco F, Borrelli F, Coppola N, Borgia G
Therapeutics and Clinical Risk Management 2014, 10:493-504
Published Date: 26 June 2014
Icosapent ethyl for the treatment of severe hypertriglyceridemia
Fares H, Lavie CJ, DiNicolantonio JJ, O’Keefe JH, Milani RV
Therapeutics and Clinical Risk Management 2014, 10:485-492
Published Date: 24 June 2014
Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women
Papaleo E, Alviggi C, Colombo GL, Pisanelli C, Ripellino C, Longobardi S, Canonico PL
Therapeutics and Clinical Risk Management 2014, 10:479-484
Published Date: 25 June 2014
The King Vision™ video laryngoscope for awake intubation: series of cases and literature review
Gaszynska E, Gaszynski T
Therapeutics and Clinical Risk Management 2014, 10:475-478
Published Date: 23 June 2014
Role of the latest endovascular technology in the treatment of intermittent claudication
Ichihashi S, Kichikawa K
Therapeutics and Clinical Risk Management 2014, 10:467-474
Published Date: 20 June 2014
Managing an outpatient parenteral antibiotic therapy team: challenges and solutions
Halilovic J, Christensen CL, Nguyen HH
Therapeutics and Clinical Risk Management 2014, 10:459-465
Published Date: 18 June 2014
Superselective transcatheter renal artery embolization for the treatment of hemorrhage from non-iatrogenic blunt renal trauma: report of 16 clinical cases
Rao D, Yu H, Zhu H, Yu K, Hu X, Xie L
Therapeutics and Clinical Risk Management 2014, 10:455-458
Published Date: 16 June 2014
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Zhong J, Roth M
Therapeutics and Clinical Risk Management 2014, 10:449-453
Published Date: 13 June 2014
Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients
Chen Y, Zhu LL, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:437-448
Published Date: 13 June 2014
New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
Gerotziafas GT, Mahé I, Elalamy I
Therapeutics and Clinical Risk Management 2014, 10:423-436
Published Date: 13 June 2014
Nature and frequency of medication errors in a geriatric ward: an Indonesian experience
Ernawati DK, Lee YP, Hughes JD
Therapeutics and Clinical Risk Management 2014, 10:413-421
Published Date: 3 June 2014
Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study
Jiang SP, Zhu ZY, Wu XL, Lu XY, Zhang XG, Wu BH
Therapeutics and Clinical Risk Management 2014, 10:405-412
Published Date: 3 June 2014
Cabozantinib for progressive metastatic medullary thyroid cancer: a review
Colombo JR, Wein RO
Therapeutics and Clinical Risk Management 2014, 10:395-404
Published Date: 28 May 2014
New treatments for genotype 1 chronic hepatitis C – focus on simeprevir
Kanda T, Nakamoto S, Wu S, Yokosuka O
Therapeutics and Clinical Risk Management 2014, 10:387-394
Published Date: 24 May 2014
The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes
Hu Y, Ding YL, Yu L
Therapeutics and Clinical Risk Management 2014, 10:381-385
Published Date: 23 May 2014
Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer – role of radium-223
Mukherji D, El Dika I, Temraz S, Haidar M, Shamseddine A
Therapeutics and Clinical Risk Management 2014, 10:373-380
Published Date: 23 May 2014
Radiation dose to the nodal regions during prone versus supine breast irradiation
Csenki M, Újhidy D, Cserháti A, Kahán Z, Varga Z
Therapeutics and Clinical Risk Management 2014, 10:367-372
Published Date: 21 May 2014
Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities
Alawneh KM, Khassawneh BY, Ayesh MH, Smadi M
Therapeutics and Clinical Risk Management 2014, 10:363-366
Published Date: 19 May 2014
Management of malignant hyperthermia: diagnosis and treatment
Schneiderbanger D, Johannsen S, Roewer N, Schuster F
Therapeutics and Clinical Risk Management 2014, 10:355-362
Published Date: 14 May 2014
Udenafil for the treatment of erectile dysfunction
Cho MC, Paick JS
Therapeutics and Clinical Risk Management 2014, 10:341-354
Published Date: 14 May 2014
Experimental study of tissue-engineered cartilage allograft with RNAi chondrocytes in vivo
Wang ZH, Li XL, He XJ, Zhang XH, Yang ZQ, Xu M, Wu BJ, Tu JB, Luo HN, Yan J
Therapeutics and Clinical Risk Management 2014, 10:335-340
Published Date: 8 May 2014
Tension-free repair during extensive radical surgery for cecal cancer with abdominal wall invasion and inguinal lymph node metastasis
Xu K, Chen Z, Song X
Therapeutics and Clinical Risk Management 2014, 10:331-334
Published Date: 8 May 2014
Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease
Iannopollo G, Camporotondo R, De Ferrari GM, Leonardi S
Therapeutics and Clinical Risk Management 2014, 10:321-329
Published Date: 2 May 2014
Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
Rakieh C, Conaghan PG
Therapeutics and Clinical Risk Management 2014, 10:313-320
Published Date: 30 April 2014
Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage
Gedik H, Şimşek F, Yıldırmak T, Kantürk A, Arıca D, Aydın D, Demirel N, Yokuş O
Therapeutics and Clinical Risk Management 2014, 10:305-312
Published Date: 28 April 2014
Acute-on-chronic liver failure: a review
Zamora Nava LE, Aguirre Valadez J, Chávez-Tapia NC, Torre A
Therapeutics and Clinical Risk Management 2014, 10:295-303
Published Date: 23 April 2014
Current and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)
Tarzi RM, Pusey CD
Therapeutics and Clinical Risk Management 2014, 10:279-293
Published Date: 17 April 2014
Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls
Gao J, Kang AJ, Lin S, Dai ZJ, Zhang SQ, Liu D, Zhao Y, Yang PT, Wang M, Wang XJ
Therapeutics and Clinical Risk Management 2014, 10:269-277
Published Date: 15 April 2014
Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster
Casale R, Mattia C
Therapeutics and Clinical Risk Management 2014, 10:259-268
Published Date: 16 April 2014
Successful percutaneous coronary intervention during cardiac arrest with use of an automated chest compression device: a case report
Libungan B, Dworeck C, Omerovic E
Therapeutics and Clinical Risk Management 2014, 10:255-257
Published Date: 11 April 2014
Prediction and prevention of the first psychotic episode: new directions and opportunities
Piras S, Casu G, Casu MA, Orrù A, Ruiu S, Pilleri A, Manca G, Marchese G
Therapeutics and Clinical Risk Management 2014, 10:241-253
Published Date: 28 March 2014
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing–remitting multiple sclerosis
Ruggieri S, Tortorella C, Gasperini C
Therapeutics and Clinical Risk Management 2014, 10:229-239
Published Date: 27 March 2014
Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
Gao CH, Yu LS, Zeng S, Huang YW, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:217-227
Published Date: 27 March 2014
“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome
Hohenforst-Schmidt W, Zarogoulidis P, Oezkan F, Mahnkopf C, Grabenbauer G, Kreczy A, Bartunek R, Darwiche K, Freitag L, Li Q, Huang H, Vogl T, LePilvert P, Tsiouda T, Tsakiridis K, Zarogoulidis K, Brachmann J
Therapeutics and Clinical Risk Management 2014, 10:207-215
Published Date: 27 March 2014
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Turpie AGG
Therapeutics and Clinical Risk Management 2014, 10:197-205
Published Date: 22 March 2014
Medication transitions and polypharmacy in older adults following acute care
Gamble JM, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT
Therapeutics and Clinical Risk Management 2014, 10:189-196
Published Date: 19 March 2014
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus
Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA
Therapeutics and Clinical Risk Management 2014, 10:173-188
Published Date: 20 March 2014
Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in The People's Republic of China
Zhu LL, Li W, Song P, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:165-172
Published Date: 17 March 2014
Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases
Dai R, Ahmed SA
Therapeutics and Clinical Risk Management 2014, 10:151-163
Published Date: 3 March 2014
Is hypertriglyceridemia a prognostic factor in sepsis?
Cetinkaya A, Erden A, Avci D, Karagoz H, Karahan S, Basak M, Bulut K, Gencer V, Mutlu H
Therapeutics and Clinical Risk Management 2014, 10:147-150
Published Date: 27 February 2014
Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes
Chávez-Tapia NC, Balderas-Garces BV, Meza-Meneses P, Herrera-Gomar M, García-López S, Gónzalez-Chon O, Uribe M
Therapeutics and Clinical Risk Management 2014, 10:139-145
Published Date: 25 February 2014
Effect of a combination of whole body vibration exercise and squat training on body balance, muscle power, and walking ability in the elderly
Osugi T, Iwamoto J, Yamazaki M, Takakuwa M
Therapeutics and Clinical Risk Management 2014, 10:131-138
Published Date: 20 February 2014
Pharmacy students' attitudes toward pharmaceutical care in Qatar
El Hajj MS, Hammad AS, Afifi HM
Therapeutics and Clinical Risk Management 2014, 10:121-129
Published Date: 18 February 2014
Postural pattern recognition in children with unilateral cerebral palsy
Domagalska-Szopa M, Szopa A
Therapeutics and Clinical Risk Management 2014, 10:113-120
Published Date: 17 February 2014
Actual preoperative fasting time in Brazilian hospitals: the BIGFAST multicenter study
Aguilar-Nascimento JE, Almeida Dias AL, Dock-Nascimento DB, Correia MITD, Campos ACL, Portari-Filho PE, Oliveira SS
Therapeutics and Clinical Risk Management 2014, 10:107-112
Published Date: 14 February 2014
Epidemiology and risk factors for invasive candidiasis
Yapar N
Therapeutics and Clinical Risk Management 2014, 10:95-105
Published Date: 13 February 2014
Active axial spondyloarthritis: potential role of certolizumab pegol
Ranatunga S, Miller AV
Therapeutics and Clinical Risk Management 2014, 10:87-94
Published Date: 12 February 2014
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K
Therapeutics and Clinical Risk Management 2014, 10:77-86
Published Date: 7 February 2014
Risk factors for an early dialysis start in patients with diabetic nephropathy end-stage renal disease
Mizuno T, Hayashi T, Kato R, Noguchi A, Hayashi H, Yuzawa Y, Yamada S, Nagamatsu T
Therapeutics and Clinical Risk Management 2014, 10:73-76
Published Date: 30 January 2014
Could a revision of the current guidelines for cancer drug use improve the quality of cancer treatment?
Lippert TH, Ruoff HJ, Volm M
Therapeutics and Clinical Risk Management 2014, 10:69-72
Published Date: 30 January 2014
Risk factors for mortality in Asian Taiwanese patients with methanol poisoning
Lee CY, Chang EK, Lin JL, Weng CH, Lee SY, Juan KC, Yang HY, Lin C, Lee SH, Wang IK, Yen TH
Therapeutics and Clinical Risk Management 2014, 10:61-67
Published Date: 17 January 2014
Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
Iwamoto J, Sato Y
Therapeutics and Clinical Risk Management 2014, 10:51-59
Published Date: 16 January 2014
Frequency of tuberculosis among diabetic patients in the People's Republic of China
Wang HT, Zhang J, Ji LC, You SH, Bai Y, Dai W, Wang ZY
Therapeutics and Clinical Risk Management 2014, 10:45-49
Published Date: 10 January 2014
Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathy
Dang Y, Sun X, Xu Y, Mu Y, Zhao M, Zhao J, Zhu Y, Zhang C
Therapeutics and Clinical Risk Management 2014, 10:37-43
Published Date: 9 January 2014
Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
Gupta HV, Farrell AM, Mittal MK
Therapeutics and Clinical Risk Management 2014, 10:27-35
Published Date: 8 January 2014
Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:17-26
Published Date: 20 December 2013
Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting
Colombo GL, Castagna A, Di Matteo S, Galli L, Bruno G, Poli A, Salpietro S, Carbone A, Lazzarin A
Therapeutics and Clinical Risk Management 2014, 10:9-15
Published Date: 18 December 2013
Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma
Feng JF, Chen QX
Therapeutics and Clinical Risk Management 2014, 10:1-7
Published Date: 16 December 2013